Troglitazone but not pioglitazone affects ATP-sensitive K+ channel activity

被引:18
作者
Sunaga, Y
Inagaki, N
Gonoi, T
Yamada, Y
Ishida, H
Seino, Y
Seino, S
机构
[1] Kyoto Univ, Grad Sch Med, Dept Metab & Clin Nutr, Sakyo Ku, Kyoto 6068501, Japan
[2] Chiba Univ, Sch Med, Dept Mol Med, Chuo Ku, Chiba 2608670, Japan
[3] Pathogen Fungi & Microbial Toxicoses Res Ctr, Chuo Ku, Chiba 2608670, Japan
关键词
K+ (K-ATP) channel; ATP-sensitive; sulfonylurea receptor; troglitazone; pioglitazone;
D O I
10.1016/S0014-2999(99)00539-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We compared the effects of the two thiazolidinedione derivatives, troglitazone and pioglitazone, on ATP-sensitive K+ (K-ATP) channel activities. Pancreatic beta-cell type and cardiac type K-ATP channels were reconstituted in COS-1 cells (SV 40-transformed African green monkey kidney (AGMK) cells) by heterologously expressing sulfonylurea receptor 1 (SUR1) plus Kir6.2 and sulfonylurea receptor 2A (SUR2A) plus Kir6.2, respectively. Troglitazone inhibited [Rb-86(+)] efflux in both K-ATP channel types in the presence of metabolic inhibitors, which was confirmed by electrophysiological techniques. The [Rb-86(+)] efflux increased by the channel openers diazoxide and pinacidil was abolished by troglitazone. In contrast, pioglitazone did not affect these channel activities in either type K-ATP channel. These results suggest that troglitazone modulates the various cellular functions including insulin secretion by inhibiting the K-ATP channels, while pioglitazone has no effect on K-ATP channel activity. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 28 条
[1]   CLONING OF THE BETA-CELL HIGH-AFFINITY SULFONYLUREA RECEPTOR - A REGULATOR OF INSULIN-SECRETION [J].
AGUILARBRYAN, L ;
NICHOLS, CG ;
WECHSLER, SW ;
CLEMENT, JP ;
BOYD, AE ;
GONZALEZ, G ;
HERRERASOSA, H ;
NGUY, K ;
BRYAN, J ;
NELSON, DA .
SCIENCE, 1995, 268 (5209) :423-426
[2]   ADENOSINE 5'-TRIPHOSPHATE-SENSITIVE POTASSIUM CHANNELS [J].
ASHCROFT, FM .
ANNUAL REVIEW OF NEUROSCIENCE, 1988, 11 :97-118
[3]   ADENOSINE-5'-TRIPHOSPHATE-SENSITIVE ION CHANNELS IN NEONATAL RAT CULTURED CENTRAL NEURONS [J].
ASHFORD, MLJ ;
STURGESS, NC ;
TROUT, NJ ;
GARDNER, NJ ;
HALES, CN .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1988, 412 (03) :297-304
[4]   Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: Binding and activation correlate with antidiabetic actions in db/db mice [J].
Berger, J ;
Bailey, P ;
Biswas, C ;
Cullinan, CA ;
Doebber, TW ;
Hayes, NS ;
Saperstein, R ;
Smith, RG ;
Leibowitz, MD .
ENDOCRINOLOGY, 1996, 137 (10) :4189-4195
[5]   INVITRO STUDIES ON THE ACTION OF CS-045, A NEW ANTIDIABETIC AGENT [J].
CIARALDI, TP ;
GILMORE, A ;
OLEFSKY, JM ;
GOLDBERG, M ;
HEIDENREICH, KA .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1056-1062
[6]   INTRACELLULAR ATP DIRECTLY BLOCKS K+ CHANNELS IN PANCREATIC B-CELLS [J].
COOK, DL ;
HALES, CN .
NATURE, 1984, 311 (5983) :271-273
[7]   15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2) IS A LIGAND FOR THE ADIPOCYTE DETERMINATION FACTOR PPAR-GAMMA [J].
FORMAN, BM ;
TONTONOZ, P ;
CHEN, J ;
BRUN, RP ;
SPIEGELMAN, BM ;
EVANS, RM .
CELL, 1995, 83 (05) :803-812
[8]   CHARACTERIZATION OF CS-045, A NEW ORAL ANTIDIABETIC AGENT .2. EFFECTS ON GLYCEMIC CONTROL AND PANCREATIC-ISLET STRUCTURE AT A LATE STAGE OF THE DIABETIC SYNDROME IN C57BL/KSJ-DB/DB MICE [J].
FUJIWARA, T ;
WADA, M ;
FUKUDA, K ;
FUKAMI, M ;
YOSHIOKA, S ;
YOSHIOKA, T ;
HORIKOSHI, H .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1991, 40 (11) :1213-1218
[9]   CHARACTERIZATION OF NEW ORAL ANTIDIABETIC AGENT CS-045 - STUDIES IN KK AND OB OB MICE AND ZUCKER FATTY RATS [J].
FUJIWARA, T ;
YOSHIOKA, S ;
YOSHIOKA, T ;
USHIYAMA, I ;
HORIKOSHI, H .
DIABETES, 1988, 37 (11) :1549-1558
[10]   MULTIPLE CONDUCTANCE STATES OF SINGLE ACETYLCHOLINE-RECEPTOR CHANNELS IN EMBRYONIC MUSCLE-CELLS [J].
HAMILL, OP ;
SAKMANN, B .
NATURE, 1981, 294 (5840) :462-464